Secondary EWSR1 gene abnormalities in SMARCB1-deficient tumors with 22q11-12 regional deletions: Potential pitfalls in interpreting EWSR1 FISH results

Genes Chromosomes and Cancer

Volumn 55, Issue 10, 2016, Pages 767-776

  Huang, Shih Chiang ^a,b   Zhang, Lei ^a   Sung, Yun Shao ^a   Chen, Chun Liang ^a   Kao, Yu Chien ^a,c   Agaram, Narasimhan P ^a   Antonescu, Cristina R ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

EWSR1 PROTEIN; PEPTIDES AND PROTEINS; SMARCB1 PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRAIN CANCER; CARCINOMA; CASE REPORT; CHILD; CHORDOMA; CHROMOSOME DELETION 22Q11; CLIVUS; DISTANT METASTASIS; EPITHELIOID SARCOMA; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FUSION GENE; GENE INACTIVATION; GENE REARRANGEMENT; GENETIC DISORDER; HETEROZYGOTE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MENINGEAL MYOEPITHELIAL NEOPLASM; MYOEPITHELIAL CARCINOMA; PRIORITY JOURNAL; RHABDOID TUMOR; SARCOMA; SKULL TUMOR;

EID: 84981266941     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.22376     Document Type: Article

References (36)

1. Agaimy A. 2014. The expanding family of SMARCB1(INI1)-deficient neoplasia: Implications of phenotypic, biological, and molecular heterogeneity. Adv Anat Pathol 21:394–410.
2. Agaram NP, Zhang L, Sung YS, Singer S, Antonescu CR. 2014. Extraskeletal myxoid chondrosarcoma with non-EWSR1-NR4A3 variant fusions correlate with rhabdoid phenotype and high-grade morphology. Hum Pathol 45:1084–1091.
3. Bayani J, Squire JA. 2007. Application and interpretation of FISH in biomarker studies. Cancer Lett 249:97–109.
4. Biegel JA, Tan L, Zhang F, Wainwright L, Russo P, Rorke LB. 2002. Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors. Clin Cancer Res 8:3461–3467.
5. Bishop JA, Antonescu CR, Westra WH. 2014. SMARCB1 (INI-1)-deficient carcinomas of the sinonasal tract. Am J Surg Pathol 38:1282–1289.
6. Calderaro J, Masliah-Planchon J, Richer W, Maillot L, Maille P, Mansuy L, Bastien C, de la Taille A, Boussion H, Charpy C, Jourdain A, Blechet C, Pierron G, Gentien D, Choudat L, Tournigand C, Delattre O, Allory Y, Bourdeaut F. 2015. Balanced translocations disrupting SMARCB1 are hallmark recurrent genetic alterations in renal medullary carcinomas. Eur Urol. [Epub ahead of print]
7. Chen S, Deniz K, Sung YS, Zhang L, Dry S, Antonescu CR. 2016. Ewing sarcoma with ERG gene rearrangements: A molecular study focusing on the prevalence of FUS-ERG and common pitfalls in detecting EWSR1-ERG fusions by FISH. Genes Chromosomes Cancer 55:340–349.
8. Fletcher CDM, Bridge JA, Hogendoorn P, Mertens F. 2013. WHO Classification of Tumours of Soft Tissue and Bone. 4th ed. Lyon, France: IARC.
9. Gozzetti A, Le Beau MM. 2000. Fluorescence in situ hybridization: Uses and limitations. Semin Hematol 37:320–333.
10. Hoch BL, Nielsen GP, Liebsch NJ, Rosenberg AE. 2006. Base of skull chordomas in children and adolescents: A clinicopathologic study of 73 cases. Am J Surg Pathol 30:811–818.
11. Hollmann TJ, Hornick JL. 2011. INI1-deficient tumors: Diagnostic features and molecular genetics. Am J Surg Pathol 35:e47–e63.
12. Huang SC, Chen HW, Zhang L, Sung YS, Agaram NP, Davis M, Edelman M, Fletcher CD, Antonescu CR. 2015. Novel FUS-KLF17 and EWSR1-KLF17 fusions in myoepithelial tumors. Genes Chromosomes Cancer 54:267–275.
13. Jackson EM, Sievert AJ, Gai X, Hakonarson H, Judkins AR, Tooke L, Perin JC, Xie H, Shaikh TH, Biegel JA. 2009. Genomic analysis using high-density single nucleotide polymorphism-based oligonucleotide arrays and multiplex ligation-dependent probe amplification provides a comprehensive analysis of INI1/SMARCB1 in malignant rhabdoid tumors. Clin Cancer Res 15:1923–1930.
14. Jahromi MS, Putnam AR, Druzgal C, Wright J, Spraker-Perlman H, Kinsey M, Zhou H, Boucher KM, Randall RL, Jones KB, Lucas D, Rosenberg A, Thomas D, Lessnick SL Schiffman JD. 2012 Molecular inversion probe analysis detects novel copy number alterations in Ewing sarcoma. Cancer Genet 205:391–404.
15. Jamshidi F, Bashashati A, Shumansky K, Dickson B, Gokgoz N, Wunder JS, Andrulis IL, Lazar AJ, Shah SP, Huntsman DG, Nielsen TO. 2016. The genomic landscape of epithelioid sarcoma cell lines and tumours. J Pathol 238:63–73.
16. Kadoch C, Hargreaves DC, Hodges C, Elias L, Ho L, Ranish J, Crabtree GR. 2013. Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy. Nat Genet 45:592–601.
17. Kohashi K, Oda Y, Yamamoto H, Tamiya S, Oshiro Y, Izumi T, Taguchi T, Tsuneyoshi M. 2008. SMARCB1/INI1 protein expression in round cell soft tissue sarcomas associated with chromosomal translocations involving EWS: A special reference to SMARCB1/INI1 negative variant extraskeletal myxoid chondrosarcoma. Am J Surg Pathol 32:1168–1174.
18. Kreiger PA, Judkins AR, Russo PA, Biegel JA, Lestini BJ, Assanasen C, Pawel BR. 2009. Loss of INI1 expression defines a unique subset of pediatric undifferentiated soft tissue sarcomas. Mod Pathol 22:142–150.
19. Le Loarer F, Zhang L, Fletcher CD, Ribeiro A, Singer S, Italiano A, Neuville A, Houlier A, Chibon F, Coindre JM, Antonescu CR. 2014. Consistent SMARCB1 homozygous deletions in epithelioid sarcoma and in a subset of myoepithelial carcinomas can be reliably detected by FISH in archival material. Genes Chromosomes Cancer 53:475–486.
20. Lee RS, Stewart C, Carter SL, Ambrogio L, Cibulskis K, Sougnez C, Lawrence MS, Auclair D, Mora J, Golub TR, Biegel JA, Getz G, Roberts CW. 2012. A remarkably simple genome underlies highly malignant pediatric rhabdoid cancers. J Clin Invest 122:2983–2988.
21. Liu Q, Galli S, Srinivasan R, Linehan WM, Tsokos M, Merino MJ. 2013. Renal medullary carcinoma: Molecular, immunohistochemistry, and morphologic correlation. Am J Surg Pathol 37:368–374.
22. Lualdi E, Modena P, Debiec-Rychter M, Pedeutour F, Teixeira MR, Facchinetti F, Dagrada GP, Pilotti S, Sozzi G. 2004. Molecular cytogenetic characterization of proximal-type epithelioid sarcoma. Genes Chromosomes Cancer 41:283–290.
23. Machado I, Lopez-Soto MV, Rubio L, Navarro L, Llombart-Bosch A. 2015. Soft tissue myoepithelial carcinoma with rhabdoid-like features and EWSR1 rearrangement: Fine needle aspiration cytology with histologic correlation. Diagn Cytopathol 43:421–426.
24. Masliah-Planchon J, Bieche I, Guinebretiere JM, Bourdeaut F, Delattre O. 2015. SWI/SNF chromatin remodeling and human malignancies. Annu Rev Pathol 10:145–171.
25. Mobley BC, McKenney JK, Bangs CD, Callahan K, Yeom KW, Schneppenheim R, Hayden MG, Cherry AM, Gokden M, Edwards MS, Fisher PG, Vogel H. 2010. Loss of SMARCB1/INI1 expression in poorly differentiated chordomas. Acta Neuropathol 120:745–753.
26. Papp G, Changchien YC, Peterfia B, Pecsenka L, Krausz T, Stricker TP, Khoor A, Donner L, Sapi Z. 2013. SMARCB1 protein and mRNA loss is not caused by promoter and histone hypermethylation in epithelioid sarcoma. Mod Pathol 26:393–403.
27. Ridenour RV, III, Ahrens WA, Folpe AL, Miller DV. 2010 Clinical and histopathologic features of chordomas in children and young adults. Pediatr Dev Pathol 13:9–17.
28. Rousseau-Merck MF, Versteege I, Legrand I, Couturier J, Mairal A, Delattre O, Aurias A. 1999. hSNF5/INI1 inactivation is mainly associated with homozygous deletions and mitotic recombinations in rhabdoid tumors. Cancer Res 59:3152–3156.
29. Soon GS, Petersson F. 2015. Beware of immunohistochemistry–report of a cytokeratin-, desmin- and INI-1-negative pelvic desmoplastic small round cell tumor in a 51 year old woman. Int J Clin Exp Pathol 8:973–982.
30. Speicher MR, Carter NP. 2005. The new cytogenetics: Blurring the boundaries with molecular biology. Nat Rev Genet 6:782–792.
31. Sullivan LM, Folpe AL, Pawel BR, Judkins AR, Biegel JA. 2013. Epithelioid sarcoma is associated with a high percentage of SMARCB1 deletions. Mod Pathol 26:385–392.
32. Swartz MA, Karth J, Schneider DT, Rodriguez R, Beckwith JB, Perlman EJ. 2002. Renal medullary carcinoma: Clinical, pathologic, immunohistochemical, and genetic analysis with pathogenetic implications. Urology 60:1083–1089.
33. Thway K, Bown N, Miah A, Turner R, Fisher C. 2015. Rhabdoid variant of myoepithelial carcinoma, with EWSR1 rearrangement: Expanding the spectrum of EWSR1-rearranged myoepithelial tumors. Head Neck Pathol 9:273–279.
34. Versteege I, Sevenet N, Lange J, Rousseau-Merck MF, Ambros P, Handgretinger R, Aurias A, Delattre O. 1998. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature 394:203–206.
35. Wilson BG, Roberts CW. 2011. SWI/SNF nucleosome remodellers and cancer. Nat Rev Cancer 11:481–492.
36. Yadav R, Sharma MC, Malgulwar PB, Pathak P, Sigamani E, Suri V, Sarkar C, Kumar A, Singh M, Sharma BS, Garg A, Bakhshi S, Faruq M. 2014. Prognostic value of MIB-1, p53, epidermal growth factor receptor, and INI1 in childhood chordomas. Neuro Oncol 16:372–381.